Literature DB >> 24801388

Mitochondria: a possible nexus for the regulation of energy homeostasis by the endocannabinoid system?

Christopher Lipina1, Andrew J Irving1, Harinder S Hundal2.   

Abstract

The endocannabinoid system (ECS) regulates numerous cellular and physiological processes through the activation of receptors targeted by endogenously produced ligands called endocannabinoids. Importantly, this signaling system is known to play an important role in modulating energy balance and glucose homeostasis. For example, current evidence indicates that the ECS becomes overactive during obesity whereby its central and peripheral stimulation drives metabolic processes that mimic the metabolic syndrome. Herein, we examine the role of the ECS in modulating the function of mitochondria, which play a pivotal role in maintaining cellular and systemic energy homeostasis, in large part due to their ability to tightly coordinate glucose and lipid utilization. Because of this, mitochondrial dysfunction is often associated with peripheral insulin resistance and glucose intolerance as well as the manifestation of excess lipid accumulation in the obese state. This review aims to highlight the different ways through which the ECS may impact upon mitochondrial abundance and/or oxidative capacity and, where possible, relate these findings to obesity-induced perturbations in metabolic function. Furthermore, we explore the potential implications of these findings in terms of the pathogenesis of metabolic disorders and how these may be used to strategically develop therapies targeting the ECS.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  2-AG; AEA; AMPK; CB1 receptor; endocannabinoid system; insulin; obesity

Mesh:

Substances:

Year:  2014        PMID: 24801388     DOI: 10.1152/ajpendo.00100.2014

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  13 in total

1.  Peripheral Endocannabinoids Associated With Energy Expenditure in Native Americans of Southwestern Heritage.

Authors:  Sascha Heinitz; Alessio Basolo; Paolo Piaggi; Daniele Piomelli; Reiner Jumpertz von Schwartzenberg; Jonathan Krakoff
Journal:  J Clin Endocrinol Metab       Date:  2018-03-01       Impact factor: 5.958

Review 2.  Emerging risk biomarkers in cardiovascular diseases and disorders.

Authors:  Ravi Kant Upadhyay
Journal:  J Lipids       Date:  2015-04-08

3.  Endocannabinoid Anandamide Mediates the Effect of Skeletal Muscle Sphingomyelins on Human Energy Expenditure.

Authors:  Sascha Heinitz; Alessio Basolo; Daniele Piomelli; Jonathan Krakoff; Paolo Piaggi
Journal:  J Clin Endocrinol Metab       Date:  2018-10-01       Impact factor: 5.958

Review 4.  Endocannabinoids at the synapse and beyond: implications for neuropsychiatric disease pathophysiology and treatment.

Authors:  Andrew Scheyer; Farhana Yasmin; Saptarnab Naskar; Sachin Patel
Journal:  Neuropsychopharmacology       Date:  2022-09-13       Impact factor: 8.294

5.  Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes.

Authors:  Dai Lu; Rachel Dopart; Debra A Kendall
Journal:  Cell Stress Chaperones       Date:  2016-01       Impact factor: 3.667

Review 6.  Integration of Nutrient Sensing in Fish Hypothalamus.

Authors:  José L Soengas
Journal:  Front Neurosci       Date:  2021-02-26       Impact factor: 4.677

7.  Cannabinoid-1 receptor regulates mitochondrial dynamics and function in renal proximal tubular cells.

Authors:  Adi Drori; Anna Permyakova; Rivka Hadar; Shiran Udi; Alina Nemirovski; Joseph Tam
Journal:  Diabetes Obes Metab       Date:  2018-09-10       Impact factor: 6.577

8.  Pharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in Muscle.

Authors:  Sergio Arrabal; Miguel Angel Lucena; Miren Josune Canduela; Almudena Ramos-Uriarte; Patricia Rivera; Antonia Serrano; Francisco Javier Pavón; Juan Decara; Antonio Vargas; Elena Baixeras; Mercedes Martín-Rufián; Javier Márquez; Pedro Fernández-Llébrez; Baukje De Roos; Pedro Grandes; Fernando Rodríguez de Fonseca; Juan Suárez
Journal:  PLoS One       Date:  2015-12-15       Impact factor: 3.240

Review 9.  The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models.

Authors:  Erica Zamberletti; Marina Gabaglio; Daniela Parolaro
Journal:  Int J Mol Sci       Date:  2017-09-07       Impact factor: 5.923

10.  THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders.

Authors:  Boris Guennewig; Maina Bitar; Ifeanyi Obiorah; James Hanks; Elizabeth A O'Brien; Dominik C Kaczorowski; Yasmin L Hurd; Panos Roussos; Kristen J Brennand; Guy Barry
Journal:  Transl Psychiatry       Date:  2018-04-25       Impact factor: 7.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.